The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors-Reference-Cited by-同舟云学术

The Role of Phosphodiesterase 12 (PDE12) as a Negative Regulator of the Innate Immune Response and the Discovery of Antiviral Inhibitors

Published:2015-08 Issue:32 Volume:290 Page:19681-19696
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Wood Edgar R.,Bledsoe Randy,Chai Jing,Daka Philias,Deng Hongfeng,Ding Yun,Harris-Gurley Sarah,Kryn Luz Helena,Nartey Eldridge,Nichols James,Nolte Robert T.,Prabhu Ninad,Rise Cecil,Sheahan Timothy,Shotwell J. Brad,Smith Danielle,Tai Vince,Taylor J. David,Tomberlin Ginger,Wang Liping,Wisely Bruce,You Shihyun,Xia Bing,Dickson Hamilton

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference52 articles.

1. Current progress in antiviral strategies;Lou;Trends Pharmacol. Sci,2014

2. A central role for RNA in the induction and biological activities of type 1 interferons;Li;Wiley Interdiscip. Rev. RNA,2011

3. Interferon-inducible antiviral effectors;Sadler;Nat. Rev. Immunol,2008

4. Viral encounters with 2′,5′-oligoadenylate synthetase and RNase L during the interferon antiviral response;Silverman;J. Virol,2007

5. Pathologic effects of RNase-L dysregulation in immunity and proliferative control;Ezelle;Front. Biosci,2012

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Study of the COVID-19 Virus: A Review;The Open COVID Journal;2024-06-06

2. PDE12 disrupts mitochondrial oxidative phosphorylation and mediates mitochondrial dysfunction to induce oral mucosal epithelial barrier damage in oral submucous fibrosis;European Journal of Pharmacology;2024-03

3. Innate Immune Activation and Mitochondrial ROS Invoke Persistent Cardiac Conduction System Dysfunction after COVID-19;2024-01-08

4. Non-coding RNAs expression in SARS-CoV-2 infection: pathogenesis, clinical significance, and therapeutic targets;Signal Transduction and Targeted Therapy;2023-12-06

5. Advancements in Phosphodiesterase 5 Inhibitors: Unveiling Present and Future Perspectives;Pharmaceuticals;2023-09-06